23 May 2013
Keywords: UCB, Neupro, Parkinson's disease, RLS, USA, FDA
Article | 03 April 2012
Belgian drugmaker UCB (Euronext Brussels: UCB) said yesterday that the US Food and Drug Administration has approved Neupro (rotigotine transdermal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2012
2 April 2012
© 2013 thepharmaletter.com